Director/PDMR Shareholding
20 March 2008 - 2:29AM
UK Regulatory
RNS Number:5003Q
GW Pharmaceuticals PLC
19 March 2008
For immediate release 19 March 2008
GW Pharmaceuticals plc
("the Company")
Notification of Interests of Directors
Following shareholder approval at yesterday's AGM of the GW Pharmaceuticals plc
Long-Term Incentive Plan, the Company has granted the following awards to
Directors over the Company's ordinary shares ("Shares").
On 19 March 2008, the Company granted the following awards in the form of
nominal-cost options ("Awards") under the GW Pharmaceuticals plc Long-Term
Incentive Plan:
Name Number of Shares under Award Total number of Shares over which
options / awards held
Dr Geoffrey Guy 170,000 1,789,914
Justin Gover 153,000 2,079,469
David Kirk 137,000 2,273,136
Dr Stephen Wright 140,000 1,177,180
The exercise price of the Awards is 0.1p per Share, the par value of the Shares.
The Awards will ordinarily vest on 19 March 2011, subject to regulatory approval
of the Company's lead product, Sativex(R), being achieved in any one of the UK,
France, Germany, Italy or Spain. Once vested, an Award may be exercised at any
time prior to the tenth anniversary of the date of grant.
For further information please contact Adam George, Company Secretary &
Financial Controller, GW Pharmaceuticals plc on 01980 557 000.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSILFFEVEIALIT
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More GW Pharmaceuticals News Articles